Literature DB >> 1352129

Specific drug binding by purified lipid-reconstituted P-glycoprotein: dependence on the lipid composition.

T Saeki1, A M Shimabuku, K Ueda, T Komano.   

Abstract

We fused P-glycoprotein with beta-galactosidase at the C-terminus aiming to study the mechanism of drug binding of P-glycoprotein in reconstitution experiments. Expression of the fusion protein in NIH 3T3 cells conferred a multidrug-resistant phenotype, suggesting that beta-galactosidase fusion at the C-terminus does not affect the functions of P-glycoprotein. The fusion protein was partially purified by simple immunoprecipitation with anti-beta-galactosidase polyclonal antibody, and its [3H]azidopine binding property was investigated in the presence of various compositions of liposomes. The purified P-glycoprotein, after reconstitution into liposomes, was capable of binding [3H]azidopine. When the cholesterol content of liposomes was increased to a weight ratio of 20%, the specific binding activity of the partially purified fusion protein was stimulated, and when the cholesterol content was increased higher, the binding activity decreased. The binding was specifically decreased by competition with vinblastine. Stigmasterol was less effective, and ergosterol was the least effective in stimulating the specific binding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352129     DOI: 10.1016/0005-2736(92)90334-i

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

Review 2.  Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.

Authors:  Chiranjeevi Peetla; Sivakumar Vijayaraghavalu; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2013-09-19       Impact factor: 15.470

3.  Heterologous expression of a mammalian ABC transporter in plant and its application to phytoremediation.

Authors:  Kazufumi Yazaki; Nao Yamanaka; Tsugumi Masuno; Satoshi Konagai; Nobukazu Shitan; Shuji Kaneko; Kazumitsu Ueda; Fumihiko Sato
Journal:  Plant Mol Biol       Date:  2006-06       Impact factor: 4.076

4.  Reconstitution of purified P-glycoprotein into liposomes.

Authors:  M Naito; T Tsuruo
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 5.  Molecular analysis of the multidrug transporter.

Authors:  U A Germann
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.

Authors:  F J Sharom; X Yu; J W Chu; C A Doige
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

7.  P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.

Authors:  Karsten Bucher; Sara Belli; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

8.  Selective modulation of P-glycoprotein-mediated drug resistance.

Authors:  M Bebawy; M B Morris; B D Roufogalis
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

Review 9.  Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function.

Authors:  Frances Jane Sharom
Journal:  Front Oncol       Date:  2014-03-03       Impact factor: 6.244

10.  Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Robert W Barnes; Arthur G Roberts
Journal:  Biosci Rep       Date:  2016-01-28       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.